Within subject variability [Power / Sample Size]

posted by MaggieSantos – Portugal, 2018-03-15 22:51 (1321 d 04:48 ago) – Posting: # 18558
Views: 3,347

Dear all,

I am exploring the hypothesis to use the within subject variability obtained on conventional 2 way crossover bioequivalence study and apply it in scale average bioequivalence as described for a replicated design used for HVD or NTI.
I know that within subject variability of reference would be necessary, but I have no replicated design. My doubt is if these values have any relation somehow like, for instance, the first one is larger than the second one or there is no relationship at all?

Kind Regards


Edit: Category changed; see also this post #1. [Helmut]

Complete thread:

 Admin contact
21,758 posts in 4,550 threads, 1,544 registered users;
online 3 (0 registered, 3 guests [including 2 identified bots]).
Forum time: Wednesday 04:39 CEST (Europe/Vienna)

There ain’t no rules around here!
We’re trying to accomplish something!    Thomas Alva Edison

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz